Value Hunters: Look To Quotient Limited (NASDAQ: QTNT)

0
98

Polar Capital LLP recently announced the acquisition of new stake in Quotient Limited (NASDAQ:QTNT). The institutional investor has increased its shareholding in the Healthcare company by 4.87% to 7.61 million shares with purchase of 0.35 million shares. This fresh investment now brings its stake to 9.44% valued currently at $56.32 million. In addition, Highbridge Capital Management LLC raised its holdings by 2.09 million to 4.16 million shares. And Columbia Management Investment Ad. has lifted its position by 17.73% or 0.55 million shares – to 3.67 million shares.

With over 0.38 million Quotient Limited (QTNT) shares trading Friday and a closing price of $8.29 on the day, the dollar volume was approximately $3.12 million. The shares have shown a positive weekly performance of 8.94% and its price on 07/17/20 gained nearly 0.97%. Currently, there are 80.27M common shares owned by the public and among those 58.06M shares have been available to trade.

An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 3 analysts who have offered their price forecasts for QTNT have a consensus price objective of $13.50. The analysts have set the share’s price value over the next 12 months at a high of $14.00 and a low of $13.00 should the stock experience a downside. The average price target is 38.59% above its last price level and an upside to the estimated low will see the stock gain 36.23% over that period. But an upside of 40.79% will see the stock hit the forecast high price target while mean target price for the stock is $13.50.

Insiders at the company have transacted a total of 50 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 47 of these insider trades were purchases, accounting for 2,965,779 shares. Insider sales of the common stock occurred on 3 occasions, with total insider shares sold totaling 44,911 shares.

The top 3 mutual fund holders in Quotient Limited are Polar Capital Funds Plc – Healthc, CS Invt. Fds. 2 – (Lux) Robotics, and ClearBridge Small Cap Fund. Polar Capital Funds Plc – Healthc owns 5.74 million shares of the company’s stock, all valued at over $42.46 million. ClearBridge Small Cap Fund now owns shares totaling to 2.73% of the shares outstanding.

Shares of Quotient Limited (NASDAQ: QTNT) opened at $8.21, unchanged from a prior closing price of $8.21. However, the script later closed the day at $8.29, up 0.97%. The company’s stock has a 5-day price change of 8.94% and 27.34% over the past three months. QTNT shares are trading -12.83% year to date (YTD), with the 12-month market performance down to -21.94% lower. It has a 12-month low price of $2.39 and touched a high of $11.30 over the same period. Currently, 0.38 million shares have been traded, compared to an average intraday trading volume of 1.11 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 6.12%, 8.28%, and 12.34% respectively.

Institutional ownership of Quotient Limited (NASDAQ: QTNT) shares accounts for 88.30% of the company’s 80.27M shares outstanding. Mutual fund holders own 31.79%, while other institutional holders and individual stakeholders account for 49.46% and 30.79% respectively.

It has a market capitalization of $660.13M and a beta (3y monthly) value of 2.64. The earnings-per-share (ttm) stands at -$1.44. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.14% over the week and 6.40% over the month.

Analysts forecast that Quotient Limited (QTNT) will achieve an EPS of -$0.33 for the current quarter, -$0.33 for the next quarter and -$1.04 for 2022. The lowest estimate earnings-per-share for the quarter is -$0.34 while analysts give the company a high EPS estimate of -$0.33. Comparatively, EPS for the current quarter was -$0.36 a year ago. Earnings per share for the fiscal year are expected to increase by 25.30%, and 22.40% over the next financial year.

Specifically, 3 Wall Street analysts polled rate the stock as a buy, while 0 of the 3 advise that investors “hold,” and 0 rated it as a “Sell.”

Looking at the support for the QTNT, a number of firms have released research notes about the stock. BTIG Research stated their Buy rating for the stock in a research note on August 31, 2017, with the firm’s price target at $12. UBS coverage for the Quotient Limited (QTNT) stock in a research note released on November 04, 2015 offered a Buy rating with a price target of $26. Jefferies was of a view on August 11, 2015 that the stock is Buy, while UBS gave the stock Buy rating on February 04, 2015, issuing a price target of $17- $25.

LEAVE A REPLY

Please enter your comment!
Please enter your name here